Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage; D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology*; D001666:Binding Sites, Antibody; D002999:Clone Cells / Q000276:immunology; D000939:Epitopes; D006168:Guinea Pigs / Q000276:immunology; D006801:Humans; D007126:Immunoglobulin Allotypes; D007140:Immunoglobulin Fab Fragments; D007135:Immunoglobulin Variable Region; D007146:Immunoglobulin lambda-Chains; D007148:Immunoglobulin mu-Chains; D007167:Immunotherapy; D007518:Isoantibodies; D007942:Leukemia, Experimental / Q000276:immunology* / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000276:immunology* / Q000628:therapy; D011947:Receptors, Antigen, B-Cell
D000888:Antibodies, Anti-Idiotypic; D000951:Antigens, Neoplasm; D000939:Epitopes; D007126:Immunoglobulin Allotypes; D007140:Immunoglobulin Fab Fragments; D007135:Immunoglobulin Variable Region; D007146:Immunoglobulin lambda-Chains; D007148:Immunoglobulin mu-Chains; D007518:Isoantibodies; D011947:Receptors, Antigen, B-Cell